Sequenom’s en banc petition rejected by Federal Circuit
02-12-2015
CAFC must end ‘existential threat’ to patents, argues Sequenom
19-08-2015
Federal Circuit invalidates Sequenom patent, cites Mayo
17-06-2015
baldyrgan / Shutterstock.com
Ariosa Diagnostics has urged the US Court of Appeals for the Federal Circuit to reject Sequenom’s en banc request, stating that behind its “sky is falling” rhetoric is really a demand for courts to revise the US Supreme Court’s two-part test in determining the eligibility of a patent.
You need a subscription to continue reading this content.
Start a subscription today to access the LSIPR website.
To access the full archive, digital magazines and special reports you will need to take out a paid subscription.
If you have already subscribed please login.
If you have any technical issues please email tech support.
For access to the complete website, archive, and to receive print publications, choose '12 MONTH SUBSCRIPTION'. For a free, two-week trial with full access, select ‘TWO WEEK FREE TRIAL’.
US Court of Appeals for the Federal Circuit; Sequenom; Ariosa; patents; US Supreme Court; Myriad; Mayo; Diehr; BIO
